Revenue (TTM) 68.76B Revenue Per Share 86.28 Gross Profit (TTM) 51.43B EBITDA (TTM) 25.04B Net Income (TTM) 9.12B EPS Diluted (TTM) $11.36Full Income Statement » RHHBY Balance Sheet Total Cash (MRQ) 19.10B Total Cash Per Share 9.66 Total Debt (MRQ) 40.09B Total Debt to Equity (...
2023, European Journal of Cancer Citation Excerpt : It would be worthwhile to consider the economic implications of this study, if bevacizumab were not to be used in women under the age of 60, where it appears to lack efficacy. The annual global revenue for originator bevacizumab (Avastin) is...
our regulatory strategy; our futurerevenue growth and profit margins; and our ability to lower our cash burn, extend operations and extend our cash runway. These statements are not guarantees of future performance and ...
--Company Name--Employees--HQ--Annual revenue--Total visits--Unknown compare to any site with our free toolstart your free trial 1 2 Benchmark Your Digital Performance Identify high-value opportunities, track your performance, and win your market. ...
--Company Name--Employees--HQ--Annual revenue--Total visits--Unknown compare to any site with our free toolstart your free trial Benchmark Your Digital Performance Identify high-value opportunities, track your performance, and win your market. ...
--Company Name--Employees--HQ--Annual revenue--Total visits--Unknown compare to any site with our free toolstart your free trial Benchmark Your Digital Performance Identify high-value opportunities, track your performance, and win your market. ...